Waldencast (NASDAQ:WALD) Stock Price Down 3.9%

Waldencast plc (NASDAQ:WALD) shares traded down 3.9% on Thursday . The stock traded as low as $5.39 and last traded at $5.39. 498 shares changed hands during trading, a decline of 99% from the average session volume of 67,966 shares. The stock had previously closed at $5.61.

Wall Street Analyst Weigh In

Separately, Telsey Advisory Group decreased their target price on shares of Waldencast from $12.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday, March 22nd.

Waldencast Trading Up 0.4 %

The firm’s 50 day moving average price is $6.75 and its two-hundred day moving average price is $8.41.

Institutional Investors Weigh In On Waldencast

Several hedge funds have recently made changes to their positions in WALD. Dynamo Internacional Gestao DE Recursos LTDA. raised its holdings in Waldencast by 4.6% during the third quarter. Dynamo Internacional Gestao DE Recursos LTDA. now owns 15,332,933 shares of the company’s stock worth $144,436,000 after purchasing an additional 674,600 shares in the last quarter. Barclays PLC raised its holdings in Waldencast by 75.3% during the third quarter. Barclays PLC now owns 7,177 shares of the company’s stock worth $67,000 after purchasing an additional 3,084 shares in the last quarter. SG Americas Securities LLC raised its holdings in Waldencast by 23.2% during the fourth quarter. SG Americas Securities LLC now owns 19,705 shares of the company’s stock worth $216,000 after purchasing an additional 3,716 shares in the last quarter. State Board of Administration of Florida Retirement System purchased a new position in Waldencast during the third quarter worth about $97,000. Finally, Bank of New York Mellon Corp raised its holdings in Waldencast by 73.6% during the third quarter. Bank of New York Mellon Corp now owns 86,409 shares of the company’s stock worth $814,000 after purchasing an additional 36,642 shares in the last quarter. Institutional investors and hedge funds own 41.97% of the company’s stock.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.